EUVIMEDEUVIMED entdecken
Systematische Übersicht

NUT Midline Carcinoma of the Head and Neck: A Systematic Review and Pooled Survival Analysis

Michelle Yoon iD, Ricardo Ramirez, Harrison Smith, Luke Stanisce iD, Soo Yeon Sohn, Margaret Brandwein-Weber, Mark Urken iD

Head & Neck · 2026

DOI: 10.1002/hed.70328 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Head & Neck, 2026. Verfasst von Michelle Yoon und 6 weiteren Autor:innen. Beteiligte Einrichtung: THANC (Thyroid, Head and Neck Cancer) Foundation, New York, New York, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Nuclear Proteins, Carcinoma, Oncogene Proteins. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

NUT midline carcinoma (NMC) is an aggressive malignancy driven by NUTM1 fusions in poorly differentiated tumor cells. This pooled analysis evaluates the impact of primary tumor location on overall survival (OS) in head and neck (HN) NMC.

Methods

A systematic review of case reports was performed. Kaplan–Meier survival analysis was used to assess OS differences by subsite, age, and genetic profile.

Results

Of 261 screened articles, 81 met inclusion criteria. Overall, 138 cases were included in demographic analyzes and 65 in survival analyzes. Tracheo‐laryngopharyngeal tumors trended toward worse OS (HR 2.45, 95% CI 1.01–5.95, p = 0.047). Orbito‐sinonasal tumors trended toward improved OS (HR 0.75, 95% CI 0.46–1.24, p = 0.25). BRD4‐NUTM1 fusions were associated with worse OS (HR 8.3, 95% CI 4.26–16.23, p = 0.0003).

Conclusions

HN NMC carries a poor prognosis, and BRD4‐NUTM1 fusions have worse outcomes. Primary subsite is a potential prognostic variable that may inform future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsNuclear ProteinsCarcinomaOncogene ProteinsHumansSurvival AnalysisFemalePrognosisOncogene Proteins, FusionKaplan-Meier EstimateMaleNeoplasm Proteins

Stichwörter der Autor:innen

NUT midline carcinomahead and neck cancersurvival

Substanzen

Nuclear ProteinsNUTM1 protein, humanOncogene ProteinsOncogene Proteins, FusionNeoplasm Proteins

Autor:innen und Institutionen

  • THANC (Thyroid, Head and Neck Cancer) Foundation, New York, New York, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Medical Education, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Department of Otolaryngology, University of Missouri School of Medicine, Springfield, Missouri, USA.
  • Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Michelle Yoon, Luke Stanisce, Mark Urken

Zitieren

APA

Yoon, M., Ramirez, R., Smith, H., Stanisce, L., Sohn, S. Y., Brandwein-Weber, M., & Urken, M. (2026). NUT Midline Carcinoma of the Head and Neck: A Systematic Review and Pooled Survival Analysis. Head & Neck. https://doi.org/10.1002/hed.70328

Vancouver

Yoon M, Ramirez R, Smith H, Stanisce L, Sohn SY, Brandwein-Weber M, et al. NUT Midline Carcinoma of the Head and Neck: A Systematic Review and Pooled Survival Analysis. Head & Neck. 2026. doi:10.1002/hed.70328

BibTeX
@article{Yoon2026,
  author = {Yoon, Michelle and Ramirez, Ricardo and Smith, Harrison and Stanisce, Luke and Sohn, Soo Yeon and Brandwein-Weber, Margaret and Urken, Mark},
  title = {NUT Midline Carcinoma of the Head and Neck: A Systematic Review and Pooled Survival Analysis},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70328}
}
Kostenlos starten →